40:
179:
and albumin. Polyethylene glycol (PEG) in a LISS solution removes water from the system and thus concentrates the antibodies present. PEG can cause non-specific aggregation of cells, thus eliminating the necessity for centrifugation after 37 °C (99 °F) incubation. PEG is not appropriate for
171:
around the suspended red blood cells, thus dispersing the repulsive negative charges and enhancing agglutination. Low ionic strength saline (LISS) is a potentiator that acts by not only reducing the
204:
out of an equal dose of an opioid medication. The potentiation can take place at any part of the liberation, absorption, distribution, metabolism and elimination of the drug.
184:. False-positive results may occur more frequently with the use of polyethylene glycol due to its strong agglutination capabilities.
253:
192:
In clinical pharmacology, a potentiator is a drug, herb, or chemical that intensifies the effects of a given drug. For example,
175:, but also by increasing the amount of antibody taken up by the red blood cell during sensitization. LISS is a solution of
104:
76:
231:
123:
83:
156:
to detect the presence of antibodies or antigens in a patient's blood sample. Examples of potentiators include
61:
90:
57:
17:
258:
72:
153:
50:
28:
8:
161:
97:
227:
197:
181:
180:
use in samples from patients with increased plasma protein, such as patients with
172:
168:
247:
157:
193:
201:
149:
39:
27:"potentiation" redirects here. For the concept in neuroscience, see
148:. Potentiators are used in the clinical laboratory for performing
176:
145:
141:
164:). Potentiators are also known as enhancement reagents.
221:
64:. Unsourced material may be challenged and removed.
245:
224:Modern Blood Banking & Transfusion Practices
167:Albumin acts as a potentiator by reducing the
160:, LISS (low ionic-strength saline) and PEG (
124:Learn how and when to remove this message
152:procedures that require enhancement of
14:
246:
200:is used to get more pain relief and
62:adding citations to reliable sources
33:
24:
144:that enhances sensitization of an
25:
270:
38:
187:
49:needs additional citations for
254:Reagents for organic chemistry
214:
13:
1:
222:Harmening, Denise M. (2005).
207:
7:
10:
275:
26:
226:. F. A. Davis Company.
29:long-term potentiation
136:In clinical terms, a
58:improve this article
162:polyethylene glycol
259:Chemical reactions
134:
133:
126:
108:
16:(Redirected from
266:
238:
237:
218:
198:dextromethorphan
182:multiple myeloma
129:
122:
118:
115:
109:
107:
66:
42:
34:
21:
274:
273:
269:
268:
267:
265:
264:
263:
244:
243:
242:
241:
234:
219:
215:
210:
190:
130:
119:
113:
110:
67:
65:
55:
43:
32:
23:
22:
15:
12:
11:
5:
272:
262:
261:
256:
240:
239:
232:
212:
211:
209:
206:
189:
186:
173:zeta potential
169:zeta potential
132:
131:
46:
44:
37:
9:
6:
4:
3:
2:
271:
260:
257:
255:
252:
251:
249:
235:
233:0-8036-1248-6
229:
225:
217:
213:
205:
203:
199:
195:
185:
183:
178:
174:
170:
165:
163:
159:
155:
154:agglutination
151:
150:blood banking
147:
143:
139:
128:
125:
117:
106:
103:
99:
96:
92:
89:
85:
82:
78:
75: –
74:
73:"Potentiator"
70:
69:Find sources:
63:
59:
53:
52:
47:This article
45:
41:
36:
35:
30:
19:
223:
216:
191:
188:Pharmacology
166:
137:
135:
120:
111:
101:
94:
87:
80:
68:
56:Please help
51:verification
48:
18:Potentiation
194:hydroxyzine
138:potentiator
248:Categories
208:References
202:anxiolysis
114:April 2009
84:newspapers
177:glycine
158:albumin
146:antigen
142:reagent
98:scholar
230:
100:
93:
86:
79:
71:
140:is a
105:JSTOR
91:books
228:ISBN
77:news
196:or
60:by
250::
236:.
220:*
127:)
121:(
116:)
112:(
102:·
95:·
88:·
81:·
54:.
31:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
